Psychiatry and Neurology, Neurology · Albany, NY
NPI
1659446391
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
47 New Scotland Ave # Mc70
Albany, NY, 12208
Phone (518) 262-5274
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
265 services
Medicare patients, 2024
201
Average age 63
Drug cost, 2024
$901K
3,147 prescriptions
Company payments, 2025
$78.95
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marianna V Spanaki-Varelas was code 95720 (neurologic), 40 times for 19 patients. In total Marianna V Spanaki-Varelas billed 265 services in 26 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-04-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95720 Neurologic | Facility | 40 | 19 | $148.34 | $5,934 |
| 95816 Neurologic | Facility | 39 | 39 | $42.46 | $1,656 |
| 99213 Office E&M - Established | Facility | 32 | 31 | $43.86 | $1,403 |
| 99215 Office E&M - Established | Facility | 31 | 30 | $98.40 | $3,051 |
| 99214 Office E&M - Established | Facility | 24 | 24 | $69.65 | $1,672 |
| 99212 Office E&M - Established | Facility | 15 | 15 | $15.91 | $239 |
By year: 2022 $19K for 251 services; 2023 $20K for 267 services; 2024 $19K for 265 services.
Medicare prescription drug claims, 2024
In 2024, the drug Marianna V Spanaki-Varelas prescribed most often to Medicare patients was Levetiracetam, with 576 prescriptions and refills. In total Marianna V Spanaki-Varelas wrote 3,147 Medicare prescriptions that cost $901K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 576 | 952 | 108 | $29K |
| Lamotrigine Generic | 421 | 665 | 63 | $8,198 |
| Topiramate Generic | 279 | 361 | 34 | $11K |
| Lacosamide Generic | 241 | 263 | 40 | $40K |
| Xcopri Cenobamate | 146 | 146 | 22 | $220K |
| Zonisamide Generic | 144 | 218 | 25 | $6,151 |
| Aptiom Eslicarbazepine Acetate | 120 | 126 | Under 11 | $158K |
| Oxcarbazepine Generic | 99 | 146 | 17 | $7,002 |
| Phenobarbital Generic | 86 | 98 | 11 | $3,165 |
| Clonazepam Generic | 85 | 85 | 18 | $1,791 |
| Clobazam Generic | 73 | 73 | 18 | $21K |
| Divalproex Sodium Er Divalproex Sodium | 73 | 123 | 14 | $5,370 |
| Gabapentin Generic | 60 | 87 | 14 | $2,063 |
| Carbamazepine Er Carbamazepine | 53 | 81 | Under 11 | $11K |
| Levetiracetam Er Levetiracetam | 47 | 95 | 12 | $4,370 |
Brand drugs: 491 claims; generic drugs: 2,570 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marianna V Spanaki-Varelas $78.95 ($78.95 in general payments such as food, travel and fees) from 3 companies. The largest payer was UCB, Inc. with $34.32.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.